Cell and Gene Therapy Catapult Ltd
CGT Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene therapies, with a vision for a thriving industry delivering life-changing advanced therapies to the world.
Years awarded: 2022
Region: East of England
Size: 250-999 employees
Sector: Pharmaceuticals and healthcare
Tackling skills shortages in the sector
Theme: Apprenticeships
The CGT Catapult introduced an industry-wide apprenticeship programme and learning platform to address skills shortages in the cell and gene therapy sector. Targets of 150 apprenticeship starts by 2022 were exceeded, with 232 apprentices, and a 92% retention rate compared to a national average of 52%. Importantly, learners have emerged as the biggest ambassadors of the programme.
News and case studies featuring Cell and Gene Therapy Catapult:
Celebrating 46 UK organisations who have outstanding workplace training programmes with HRH The Princess Royal
London, Thursday 8th December: On Tuesday 6th December, Her Royal Highness The Princess Royal, welcomed 46 organisations to Banqueting House in London to celebrate successfully achieving a Princess Royal Training Award for their commitment to training and...
Outstanding workplace training programmes recognised in HRH The Princess Royal’s training awards
HRH The Princess Royal, President of City & Guilds, awards employers with outstanding training and skills development programmes which have been proven to have significant positive impact on their business or their staff More apprenticeship programmes have been...